금융 뉴스 허브

Earnings Snapshot: Accenture posts $18.7B in Q3 revenue; new bookings slide slightly

Roche lymphoma therapy undergoes FDA review for label expansion

3 Reasons TMO is Risky and 1 Stock to Buy Instead

Over the last six months, Thermo Fisher’s shares have sunk to $464.50, producing a disappointing 17.4% loss - a stark contrast to the S&P 500’s 10.9% gain. This might have investors contemplating thei ...

Swiss Franc: SNB neutrality keeps Franc pressured – BBH

Brown Brothers Harriman reports the Swiss National Bank left its policy rate at 0.00% for a fourth meeting, characterizing the decision as a neutral hold.

United States Dollar: Haven status tested by Fed shift – Rabobank

Rabobank’s FX Strategy team notes the Dollar has recently been supported by both safe haven demand and shifting expectations for Federal Reserve policy.

Rumble jumps 17% after Northern Data acquisition, renames cloud unit Quake AI

Kroger Non-GAAP EPS of $1.58 misses by $0.01, revenue of $46.12B beats by $590M

The next two weeks could bring a bumpy ride for U.S. stocks. Buy any dip, says this strategist.

Citadel strategist Scott Rubner says one of the most important two weeks of the year is here, and that could open buying opportunities for stocks.

Dick's (DKS): Buy, Sell, or Hold Post Q1 Earnings?

Dick's has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 6.8% to $224.38 per share while the index has gained 10.9%.

Accenture GAAP EPS of $3.80 beats by $0.11, revenue of $18.7B misses by $50M

MRVL Stock Rises Premarket: Marvell Ships Over 5M Photonic Chips Ahead Of S&P 500 Entry

The company and Tower Semiconductor have shipped photonic integrated circuits to Marvell’s customers.

Carnival's Holland America eyes expansion in the Mediterranean